203 related articles for article (PubMed ID: 38278150)
61. Radiofrequency ablation in combination with CD73 inhibitor AB680 reduces tumor growth and enhances anti-tumor immunity in a syngeneic model of pancreatic ductal adenocarcinoma.
Faraoni EY; Strickland LN; O'Brien BJ; Barraza JF; Thosani NC; Wray CJ; Mills TW; Bailey-Lundberg JM
Front Oncol; 2022; 12():995027. PubMed ID: 36147911
[TBL] [Abstract][Full Text] [Related]
62. Adenosine deaminase-adenosine pathway in hemolysis-associated pulmonary hypertension.
Tofovic SP; Jackson EK; Rafikova O
Med Hypotheses; 2009 Jun; 72(6):713-9. PubMed ID: 19237250
[TBL] [Abstract][Full Text] [Related]
63. Improving the anti-solid tumor efficacy of CAR-T cells by inhibiting adenosine signaling pathway.
Li N; Tang N; Cheng C; Hu T; Wei X; Han W; Wang H
Oncoimmunology; 2020 Sep; 9(1):1824643. PubMed ID: 33457103
[TBL] [Abstract][Full Text] [Related]
64. Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer.
Zhulai G; Oleinik E; Shibaev M; Ignatev K
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327609
[TBL] [Abstract][Full Text] [Related]
65. Adenosine produced by neurons is metabolized to hypoxanthine by astrocytes.
Zamzow CR; Xiong W; Parkinson FE
J Neurosci Res; 2008 Nov; 86(15):3447-55. PubMed ID: 18627033
[TBL] [Abstract][Full Text] [Related]
66. Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL.
Zhang T; Liu H; Jiao L; Zhang Z; He J; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; Zhang H; Wang X
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35365585
[TBL] [Abstract][Full Text] [Related]
67. Secretion of human soluble programmed cell death protein 1 by chimeric antigen receptor-modified T cells enhances anti-tumor efficacy.
Zhang A; Sun Y; Wang S; Du J; Gao X; Yuan Y; Zhao L; Yang Y; Xu L; Lei Y; Duan L; Xu C; Ma L; Wang J; Hu G; Chen H; Wang Q; Hu L; Zhang B
Cytotherapy; 2020 Dec; 22(12):734-743. PubMed ID: 32684339
[TBL] [Abstract][Full Text] [Related]
68. Development of a microfluidic cell transfection device into gene-edited CAR T cell manufacturing workflow.
Yu T; Jhita N; Shankles P; Fedanov A; Kramer N; Raikar SS; Sulchek T
Lab Chip; 2023 Nov; 23(22):4804-4820. PubMed ID: 37830228
[TBL] [Abstract][Full Text] [Related]
69. Inhibition of Calcium Signaling Prevents Exhaustion and Enhances Anti-Leukemia Efficacy of CAR-T Cells via SOCE-Calcineurin-NFAT and Glycolysis Pathways.
Shao M; Teng X; Guo X; Zhang H; Huang Y; Cui J; Si X; Ding L; Wang X; Li X; Shi J; Zhang M; Kong D; Gu T; Hu Y; Qian P; Huang H
Adv Sci (Weinh); 2022 Mar; 9(9):e2103508. PubMed ID: 35032108
[TBL] [Abstract][Full Text] [Related]
70. Inosine, gut microbiota, and cancer immunometabolism.
Samami E; Aleebrahim-Dehkordi E; Mohebalizadeh M; Yaribash S; Saghazadeh A; Rezaei N
Am J Physiol Endocrinol Metab; 2023 Jan; 324(1):E1-E8. PubMed ID: 36416582
[TBL] [Abstract][Full Text] [Related]
71. Breast Cancer Cell-Derived Adenosine Enhances Generation and Suppressor Function of Human Adaptive Regulatory T Cells.
Mandapathil M; Szczepanski MJ; Jackson EK; Lang S; Whiteside TL
J Pers Med; 2021 Jul; 11(8):. PubMed ID: 34442398
[TBL] [Abstract][Full Text] [Related]
72. Hydroxycarbamide modulates components involved in the regulation of adenosine levels in blood cells from sickle-cell anemia patients.
Silva-Pinto AC; Dias-Carlos C; Saldanha-Araujo F; Ferreira FI; Palma PV; Araujo AG; Queiroz RH; Elion J; Covas DT; Zago MA; Panepucci RA
Ann Hematol; 2014 Sep; 93(9):1457-65. PubMed ID: 24696091
[TBL] [Abstract][Full Text] [Related]
73. A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation.
Morandi F; Morandi B; Horenstein AL; Chillemi A; Quarona V; Zaccarello G; Carrega P; Ferlazzo G; Mingari MC; Moretta L; Pistoia V; Malavasi F
Oncotarget; 2015 Sep; 6(28):25602-18. PubMed ID: 26329660
[TBL] [Abstract][Full Text] [Related]
74. Enhancement of inosine-mediated A
Welihinda AA; Kaur M; Raveendran KS; Amento EP
Cell Signal; 2018 Jan; 42():227-235. PubMed ID: 29126977
[TBL] [Abstract][Full Text] [Related]
75. The Multifaceted Actions of CD73 During Development and Suppressive Actions of Regulatory T Cells.
Da M; Chen L; Enk A; Ring S; Mahnke K
Front Immunol; 2022; 13():914799. PubMed ID: 35711418
[TBL] [Abstract][Full Text] [Related]
76. Elevated CD39+T-Regulatory Cells and Reduced Levels of Adenosine Indicate a Role for Tolerogenic Signals in the Progression from Moderate to Severe COVID-19.
Elsaghir A; El-Sabaa EMW; Zahran AM; Mandour SA; Salama EH; Aboulfotuh S; El-Morshedy RM; Tocci S; Mandour AM; Ali WE; Abdel-Wahid L; Sayed IM; El-Mokhtar MA
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139439
[TBL] [Abstract][Full Text] [Related]
77. Endogenous luminal surface adenosine signaling regulates duodenal bicarbonate secretion in rats.
Ham M; Mizumori M; Watanabe C; Wang JH; Inoue T; Nakano T; Guth PH; Engel E; Kaunitz JD; Akiba Y
J Pharmacol Exp Ther; 2010 Dec; 335(3):607-13. PubMed ID: 20805305
[TBL] [Abstract][Full Text] [Related]
78. Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death.
Bao X; Xie L
J Exp Clin Cancer Res; 2022 Jul; 41(1):222. PubMed ID: 35836249
[TBL] [Abstract][Full Text] [Related]
79. The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy.
Jiang X; Wu X; Xiao Y; Wang P; Zheng J; Wu X; Jin Z
Front Immunol; 2023; 14():1110325. PubMed ID: 36776866
[TBL] [Abstract][Full Text] [Related]
80. A Near-Infrared-II Fluorescent Nanocatalyst for Enhanced CAR T Cell Therapy against Solid Tumor by Immune Reprogramming.
Li H; Yang X; Wang Z; She W; Liu Y; Huang L; Jiang P
ACS Nano; 2023 Jun; 17(12):11749-11763. PubMed ID: 37319120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
